CME Group (CME) Gets Buy Rating From Erste Group; Argus Research Moves to Hold

CME Group Inc. (NASDAQ:CME) is included among the 14 Stocks on the Verge of Becoming Dividend Aristocrats.

CME Group (CME) Gets Buy Rating From Erste Group; Argus Research Moves to Hold

On March 5, Hans Engel of Erste Group upgraded CME Group Inc. (NASDAQ:CME) to Buy from Hold. A day earlier, on March 4, Argus Research downgraded CME Group to Hold from Buy. The firm expects “muted growth” in several parts of the company’s business. These include equity index, metals, crypto, and micro contracts traded by retail investors. At the same time, the analyst believes stronger activity in agriculture and prediction markets could help offset some of that slowdown, according to the research note.

On March 9, CME Group reported a new milestone in its energy trading business. The company said its energy complex reached a single-day volume record of 8.3 million contracts on March 6. That figure surpassed the previous daily record of 7.9 million contracts set just days earlier, on March 3, 2026. Trading activity across the complex produced several additional records that day. Energy options volume reached 1.43 million contracts, crude oil complex volume climbed to 5.73 million contracts, and Micro Crude Oil futures also hit a record, with 748,729 contracts traded.

Activity in refined products was also strong. CME Group Refined Products, driven by RBOB Gasoline futures and New York Harbor Ultra-low Sulfur Diesel futures, reached a new single-day record of 1.25 million contracts on March 3, 2026. All five of the top-performing volume days for the refined products complex occurred during the past week. That surge pushed the five-day average volume to 1.09 million contracts.

CME Group Inc. (NASDAQ:CME) operates a global derivatives marketplace. Its platforms allow clients to trade futures, options, cash products, and over-the-counter markets. The company’s exchanges list benchmark products across major asset classes, including interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

While we acknowledge the potential of CME to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CME and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading into 2026 and 13 Best REIT Dividend Stocks to Invest in

Disclosure: None.  Follow Insider Monkey on Google News.